Integrating behavioral interventions into a holistic approach to metabolic dysfunction-associated steatotic liver disease.

The treatment of MASLD should not rely solely on pharmacotherapy targeting a single-organ manifestation. Instead, we must consider behavioral interventions, emphasizing the pivotal role of a holistic approach to this multifaceted disorder. [Figure: see text].